Science Explorer Back to mapMap
Discussion
Company · Kirkland · United States

Aminex Therapeutics (United States)

aminextx.comROR OpenAlex
Research works
10
▲ 6% vs 2018-21
Citations
208
21.7 per fractional work
Top-10% rate
10.6%
all institutions 10.0%
Open access
78%
world 40%
International
56%
world 18%
Aminex Therapeutics (United States)

Not ranked overall: Aminex Therapeutics (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Aminex Therapeutics (United States) work in?

In all years, 61% of research at Aminex Therapeutics (United States) is in Life Sciences, 24% in Health Sciences. Its largest fields are Biochemistry, Genetics and Molecular Biology (55%), Medicine (24%), Engineering (14%). It does 2.0× the world's share of Life Sciences.

Life Sciences: 6 fractional works · 60.9% of its workBiochemistry, Genetics and Molecular Biology: 5 fractional works · 55.2% of its workMolecular Biology: 2 fractional works · 24.8% of its workBiochemistry: 1 fractional works · 11.2% of its workBiotechnology: 1 fractional works · 9.0% of its workCancer Research: 0 fractional works · 4.8% of its workGenetics: 0 fractional works · 3.4% of its workClinical Biochemistry: 0 fractional works · 1.1% of its workCell Biology: 0 fractional works · 0.8% of its workImmunology and Microbiology: 0 fractional works · 5.2% of its workImmunology: 0 fractional works · 5.2% of its workNeuroscience: 0 fractional works · 0.5% of its workCellular and Molecular Neuroscience: 0 fractional works · 0.5% of its workHealth Sciences: 2 fractional works · 24.5% of its workMedicine: 2 fractional works · 24.0% of its workNeurology: 0 fractional works · 5.0% of its workSurgery: 0 fractional works · 4.7% of its workHematology: 0 fractional works · 3.1% of its workOncology: 0 fractional works · 3.1% of its workRheumatology: 0 fractional works · 1.8% of its workPharmacology: 0 fractional works · 1.5% of its workRadiology, Nuclear Medicine and Imaging: 0 fractional works · 1.5% of its workEpidemiology: 0 fractional works · 0.8% of its workGenetics: 0 fractional works · 0.8% of its workPediatrics, Perinatology and Child Health: 0 fractional works · 0.7% of its workEmergency Medicine: 0 fractional works · 0.5% of its workPsychiatry and Mental health: 0 fractional works · 0.5% of its workDentistry: 0 fractional works · 0.5% of its workOral Surgery: 0 fractional works · 0.5% of its workPhysical Sciences: 1 fractional works · 14.6% of its workEngineering: 1 fractional works · 13.9% of its workBuilding and Construction: 1 fractional works · 6.0% of its workAerospace Engineering: 0 fractional works · 3.4% of its workCivil and Structural Engineering: 0 fractional works · 2.6% of its workBiomedical Engineering: 0 fractional works · 1.8% of its workMaterials Science: 0 fractional works · 0.7% of its workMaterials Chemistry: 0 fractional works · 0.7% of its workALL ITS WORKAminexTherapeutics…10fractional works, all years
Life Sciences61%Physical Sciences15%Health Sciences24%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 3 domains and 7 fields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology555.2%
    2. Immunology and Microbiology05.2%
    3. Neuroscience00.5%
    1. Medicine224.0%
    2. Dentistry00.5%
    1. Engineering113.9%
    2. Materials Science00.7%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Who are the top researchers at Aminex Therapeutics (United States)?

Ranked on the quality score, Mark R. Burns lead among researchers whose main affiliation is Aminex Therapeutics (United States).

  1. 1 Mark R. Burns United States · #695,258 worldwide 2.1k citations · 68 works
All ranked researchers at Aminex Therapeutics (United States)

What are the most cited papers from Aminex Therapeutics (United States)?

The most cited paper from Aminex Therapeutics (United States) is "Polyamine-Blocking Therapy Reverses Immunosuppression in the Tumor Microenvironment" (Candace S. Hayes, Allyson C. Shicora, Martin P. Keough et al., 2013), with 169 citations. Next come "Inhibition of polyamine synthesis and uptake reduces tumor progression and prolongs survival in mouse models of neuroblastoma" (163) and "Dual targeting of polyamine synthesis and uptake in diffuse intrinsic pontine gliomas" (131).

Most cited papers
#PaperReleasedCitations
1 Polyamine-Blocking Therapy Reverses Immunosuppression in the Tumor Microenvironment Candace S. Hayes, Allyson C. Shicora, Martin P. Keough et al. · Cancer Immunology Research Open access 7 Oct 2013 169
2 Inhibition of polyamine synthesis and uptake reduces tumor progression and prolongs survival in mouse models of neuroblastoma Laura D. Gamble et al. · Science Translational Medicine Open access 30 Jan 2019 163
3 Dual targeting of polyamine synthesis and uptake in diffuse intrinsic pontine gliomas Aaminah Khan, Laura D. Gamble, Dannielle H. Upton et al. · Nature Communications Open access 12 Feb 2021 131
4 Polyamines drive myeloid cell survival by buffering intracellular pH to promote immunosuppression in glioblastoma Jason M. Miska, Aida Rashidi, Catalina Lee-Chang et al. · Science Advances Open access 17 Feb 2021 118
5 AMXT-1501, a novel polyamine transport inhibitor, synergizes with DFMO in inhibiting neuroblastoma cell proliferation by targeting both ornithine decarboxylase and polyamine transport Katherine Samal, Ping Zhao, Ann Kendzicky et al. · International Journal of Cancer Open access 2 Mar 2013 95
All 25 most cited papers, with filters and sorting

Which research topics does Aminex Therapeutics (United States) publish most on?

By volume in 2022-now: Polyamine Metabolism and Applications, Cancer Research and Treatments, Neuroblastoma Research and Treatments and Amino Acid Enzymes and Metabolism.

Polyamine Metabolism and…1Polyamine Metabolism and Applications: 1 fractional worksCancer Research and Treatments: 0 fractional worksNeuroblastoma Research and Treatments: 0 fractional worksAmino Acid Enzymes and Metabolism: 0 fractional worksCancer, Hypoxia, and Metabolism: 0 fractional worksNeonatal Health and Biochemistry: 0 fractional worksPancreatic function and diabetes: 0 fractional worksEpigenetics and DNA Methylation: 0 fractional worksMicrobial metabolism and enzyme function: 0 fractional worksGlioma Diagnosis and Treatment: 0 fractional works
Molecular BiologyBiotechnologyNeurologyBiochemistry4 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Polyamine Metabolism and Applications Molecular Biology 1 works
  2. 2 Cancer Research and Treatments Biotechnology 0 works
  3. 3 Neuroblastoma Research and Treatments Neurology 0 works
  4. 4 Amino Acid Enzymes and Metabolism Biochemistry 0 works
  5. 5 Cancer, Hypoxia, and Metabolism Cancer Research 0 works
  6. 6 Neonatal Health and Biochemistry Pediatrics, Perinatology and Child Health 0 works
  7. 7 Pancreatic function and diabetes Surgery 0 works
  8. 8 Epigenetics and DNA Methylation Molecular Biology 0 works
  9. 9 Microbial metabolism and enzyme function Molecular Biology 0 works
  10. 10 Glioma Diagnosis and Treatment Genetics 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available78.1%not open21.9%

World: 40% of research is openly available.

with international co-authors56.2%domestic only43.8%

World: 18% is written across borders.

How has Aminex Therapeutics (United States)'s research output changed?

Output in 2022-2025 was 6% higher than in 2018-2021.

still counting200020052010201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Aminex Therapeutics (United States) as a percentage of every work published that year, 0.000015% in 2024.

still counting0.000020%0.000040%0.000060%Aminex Therapeutics (United States)0.000013% in 2025200020102020

Fractional works of Aminex Therapeutics (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Kirkland

All research institutions in Kirkland

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Aminex Therapeutics (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.